[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::811036897883492352.png) @BiopharmIQ BiopharmIQ by Amp

Several biotech companies have recently made significant announcements, including $INBX, which saw a XX% increase in stock value after releasing positive topline results for its chondrosarcoma trial. $RNA entered into an acquisition agreement for $XX billion, and $NVS is set to acquire $RNA's neuro pipeline. Additionally, $GMAB is acquiring $MRUS for $X billion, expanding its portfolio with a phase X bispecific petosemtamab.

### Engagements: XXXXXX [#](/creator/twitter::811036897883492352/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:interactions.svg)

- X Week XXXXXX +61%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +18%
- X Year XXXXXXXXX -XX%

### Mentions: XX [#](/creator/twitter::811036897883492352/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX -XX%
- X Year XXXXX -XX%

### Followers: XXXXXX [#](/creator/twitter::811036897883492352/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:followers.svg)

- X Week XXXXXX +0.61%
- X Month XXXXXX +1.60%
- X Months XXXXXX +14%
- X Year XXXXXX +23%

### CreatorRank: XXXXXXX [#](/creator/twitter::811036897883492352/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  #2071 [finance](/list/finance)  XXXXX% [countries](/list/countries)  XXX% [technology brands](/list/technology-brands)  XXX% [exchanges](/list/exchanges)  XXX% [currencies](/list/currencies)  XXX%

**Social topic influence**
[$iron](/topic/$iron) #2, [future](/topic/future) 10.99%, [$gpcr](/topic/$gpcr) #1, [$xcur](/topic/$xcur) #1, [$advm](/topic/$advm) #4, [$aclx](/topic/$aclx) #2, [q4](/topic/q4) #21, [$nktr](/topic/$nktr) #1, [$bmy](/topic/$bmy) #6, [$ewtx](/topic/$ewtx) #3

**Top accounts mentioned or mentioned by**
[@yaireinhorn](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@bowtiedbiotechs](/creator/undefined) [@biotech2k1](/creator/undefined) [@amaymd](/creator/undefined) [@learnbiotech](/creator/undefined) [@pharmdca](/creator/undefined) [@bioinvestor24](/creator/undefined) [@geneinvesting](/creator/undefined) [@ohadhammer](/creator/undefined) [@drsamuelbhume](/creator/undefined) [@lifescivc](/creator/undefined) [@desertdweller93](/creator/undefined) [@biostocks](/creator/undefined) [@sma](/creator/undefined) [@isid](/creator/undefined) [@seedy19tron](/creator/undefined) [@hatedmoats](/creator/undefined) [@andreagtc](/creator/undefined) [@pearlf](/creator/undefined)

**Top assets mentioned**
[Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Curate (XCUR)](/topic/$xcur) [Adverum Biotechnologies, Inc. Common Stock (ADVM)](/topic/$advm) [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) [Incyte Corporation (INCY)](/topic/$incy) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Insmed, Inc. (INSM)](/topic/$insm) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Eli Lilly and Company (LLY)](/topic/$lly) [CG Oncology, Inc. Common stock (CGON)](/topic/$cgon) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Mineralys Therapeutics, Inc. Common Stock (MLYS)](/topic/$mlys) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [GSK plc (GSK)](/topic/$gsk) [SuperRare (RARE)](/topic/$rare) [AltLayer (ALT)](/topic/$alt) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [uniQure N.V. (QURE)](/topic/$qure) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Alkermes Inc. plc (ALKS)](/topic/$alks) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Arcutis Biotherapeutics, Inc. Common Stock (ARQT)](/topic/$arqt) [Amgen, Inc. (AMGN)](/topic/$amgn) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [ADC Therapeutics SA (ADCT)](/topic/$adct) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Alcon Inc. Ordinary Shares (ALC)](/topic/$alc) [Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)](/topic/$amrx) [Vaxcyte, Inc. Common Stock (PCVX)](/topic/$pcvx) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Marblex (MBX)](/topic/$mbx) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Mist (MIST)](/topic/$mist)
### Top Social Posts
Top posts by engagements in the last XX hours

"RA Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND (25.0%) $RYTM (7.1%) $PCVX (5.3%) $RNA (4.6%) $CDTX (4.0%) $SION (3.8%) $ETNB (3.6%) $NAMS (3.6%) $MLYS (3.4%) $JANX (3.4%) $ACLX (3.1%) $LENZ (2.4%) $TYRA (2.1%) $EWTX (2.1%) $WVE (1.6%) $SEPN (1.6%) $DNTH (1.4%) $BCAX (1.4%) $GHRS (1.4%) $SPRY (1.3%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"  
[X Link](https://x.com/BiopharmIQ/status/1989462851313160562)  2025-11-14T22:38Z 28.1K followers, 9476 engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $IFRX Phase 2a $IFRX Phase 2b $VRCA Phase X $KZR Phase 2a $CRDL Phase X $ARTV Phase 2a $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT"  
[X Link](https://x.com/BiopharmIQ/status/1987607301608644788)  2025-11-09T19:44Z 28.1K followers, 33.9K engagements


"📌 Biotech Stock News 12/2 @ Open $NRXP X% FDA Receives ANDA for KETAFREE $JSPR X% ETESIAN Study Positive Data $TLSA X% Plans to Spinout IL-6 Asset $SGMO X% FDA Fast Track for ST-503 $PDSB X% Scheduling of Type C Meeting with FDA $RHHBY X% FDA Clearance for Point-of-Care Test $BFRI X% Filing of sNDA for sBCC Treatment $ARWR X% Plozasiran Breakthrough Tx Designation $ENGN X% Detalimogene Selected for FDA Pilot $PCRX X% 12-Month Study Shows Pain Improvement $LGVN X% Granted Patent for Stem Cell Method $HRMY X% New Data from Phase X ARGUS Trial $NTRA X% Presenting XX Datasets at Symposium $JAGX"  
[X Link](https://x.com/BiopharmIQ/status/1995897918533095466)  2025-12-02T16:48Z 28.1K followers, 4051 engagements


"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved $BMY - Breyanzi (lisocabtagene maraleucel) - Approved $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea"  
[X Link](https://x.com/BiopharmIQ/status/1996984941549433177)  2025-12-05T16:48Z 28.1K followers, 36.9K engagements


"$JANX down -XX% 📉 JANX007 showed 8-month RPFS in mCRPC PSA drops and partial responses reported CRS mainly grade XX and seen early in treatment Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1995897922815492281)  2025-12-02T16:48Z 28.1K followers, 1137 engagements


"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 12/5/25 📈 $CAPR XXX% Deramiocel Topline Results Reported $QTTB XX% Sells Complement Inhibitor ADX-097 $PRAX XX% Relutrigine Results; Ulixacaltamide Pre-NDA Mtg. $PHVS XX% Deucrictibant Topline Data Reported $GUTS XX% Positive 6-Month REVEAL-1 Results 📉 $JANX -XX% Ph1 JANX007 Efficacy & Safety Profile $BDTX -XX% Silevertinib Preliminary Ph2 Data $CLNN -XX% CNM-Au8 ALS Biomarker Results $TARA -XX% Pricing of $75M Offering $SPRC -XX% Entering Multi-Billion-Dollar GERD Device Market"  
[X Link](https://x.com/BiopharmIQ/status/1997067918719570222)  2025-12-05T22:17Z 28.1K followers, 12.4K engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $LGVN Phase 2a $INMB Phase X $AVXL Phase 2/3 $STOK Phase X $ACLX Phase X $IRON Phase X $GLPG Phase X $NRIX Phase X $XCUR Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $AMGN Phase X $INCY Phase X $BINV"  
[X Link](https://x.com/BiopharmIQ/status/1995242784832565668)  2025-11-30T21:25Z 28.1K followers, 73.5K engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $STOK Phase X $HRMY Phase X $RXRX Phase X $XCUR Phase X $IMMP Phase 2/3 $PVLA Phase X $LTRN Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $SLS Phase X $MGTX Phase X $IDYA Phase 2/3 $DWTX Phase 2b $WVE Phase X $EWTX Phase X $ZYME Phase X $ZVSA Phase 2a $BHVN Phase X $VTYX Phase X $DBVT Phase X $VTGN Phase X $INBX Phase 2/3 $LSTA Phase 2a $ADVM Phase X $ALT Phase 2b $ACIU Phase X $RYTM Phase X $ATOS Phase 2"  
[X Link](https://x.com/BiopharmIQ/status/1997779928784519535)  2025-12-07T21:27Z 28.1K followers, 38.3K engagements


"🧬 Biotech Stock News 08/19 Brought to you by Barb X stocks on the rise 📈 $EVFM $IOVA $PTCT X under pressure 📉 $ALXO $BTAI $VKTX Catch the full breakdown in the latest video 🎥"  
[X Link](https://x.com/BiopharmIQ/status/1957852319833551221)  2025-08-19T17:09Z 28.1K followers, 3860 engagements


"📌 Biotech Stock News 09/17 @ Open $ROIV XX% Brepocitinib Ph3 Study Results $ORKA XX% ORKA-001 Interim Ph1 Results $ELTX X% ELI-002 Trial Update $ATXS X% Ph1a Trial Initial Results $NRIX X% Preclin Data on IRAK4 Degrader $AKTX X% New Patent Filing for ADC Platform $ARQT X% New ZORYVE Data Analyses $TNXP X% In-licensing of TNX-4800 $XFOR X% Restructuring of Business Operations $CLDX X% Barzolvolimab Data at EADV $PTGX X% PN-881 Data at EADV $CDTX X% CD388 Ph2b Data $CADL X% Ph3 Results of CAN-2409 $VTRS X% First Patient Recruited in Ph2/3 Study $REGN X% Ph2 Trial Results on GLP-1 Receptor"  
[X Link](https://x.com/BiopharmIQ/status/1968359434712912171)  2025-09-17T17:00Z 28.1K followers, 9354 engagements


"100% approval month 💥 Every drug/PDUFA in Oct got approved $JAZZ Zepzelca + Tecentriq $ARQT ZORYVE (roflumilast) Cream XXXX% $AMGN Tezspire $GKOS Epioxa (Epi-on) $GSK Blenrep combinations (BVd & BPd) $SNDX Revuforj (revumenib) $MRK WINREVAIR (sotatercept-csrk) $RHHBY Gazyva/Gazyvaro $REGN Libtayo (cemiplimab) Updated calendar below"  
[X Link](https://x.com/BiopharmIQ/status/1985446857313828989)  2025-11-03T20:39Z 28.1K followers, 24.4K engagements


"📌 Biotech Stock News 11/25 @ Open $AUTL XX% Treatment Option for R/R B-ALL $CTXR X% Exhibit at ASH Annual Meeting $BIIB X% Completes Rolling Submission for LEQEMBI $XENE X% New Azetukalner OLE Study Data $LLY X% Data from Phase X studies presented $BMY X% Approval to Expand CAR T Therapy $RAPP X% New Phase 2a Data Analysis $SRPT X% Approval for ENDEAVOR Cohort X $REGN X% First Targeted Medicine Approved for CSU $TLSA X% Nasal Foralumab Phase X Trial Accepted $TEVA X% EU Commission approvals for biosimilars $TELO X% New Data Reduces PSA Levels $NVCT -X% Virtual Meeting on NXP900 Program $NUVL"  
[X Link](https://x.com/BiopharmIQ/status/1993367555327901725)  2025-11-25T17:13Z 28.1K followers, 2500 engagements


"🧬 Biotech Stock News 12/01 @ Open $QTTB XXX% Sells Complement Inhibitor ADX-097 $MAIA XX% Open Market Purchases by CEO & Directors $BLTE X% Positive Results from Phase X Trial $PMN X% New Publication on Plasma pTau in Alzheimer's $RDHL X% Regains Compliance with Nasdaq $OMER X% Closing of Asset Purchase Agreement $AAPG X% Webcast Highlighting Key Data from ASH 2025 $BMY X% Data Showcase Hematology Pipeline Potential $VTRS X% Seeking Partnerships for Long-Acting Depot Drugs $MIRM X% First Patient Enrolled in BLOOM Study $MNKD -X% FDA Review of FUROSCIX Autoinjector $BCDA -X% Present at Heart"  
[X Link](https://x.com/BiopharmIQ/status/1995521196180615335)  2025-12-01T15:51Z 28.1K followers, 6231 engagements


"🧬 Biopharma Weekly Recap 📝 This week in biotech: China dealmaking surges obesity programs and competitive dynamics intensify FDA shifts spotlight reviews and rare disease and cell therapy updates drive focus. See interesting posts/ppl to check out 👇 @Biotech2k1 Biotech Forever X names cited with high sales estimates ($INSM $BBIO $AXSM $CRNX $CYTK $PTXG $IDYA $COGT); outlook noted as subject to change. @ohadhammer Jefferies: China biotech showing record activity and R&D productivity; key issue is program differentiation. @PearlF An updated FDA org chart from @biospace @DrSamuelBHume 5"  
[X Link](https://x.com/BiopharmIQ/status/1997320319837917346)  2025-12-06T15:00Z 28.1K followers, 26.5K engagements


"🩸 ASH 2025 continues ending tomorrow Here are the presentations pulled from todays news: $FULC XX% Positive Results from PIONEER Trial $NRIX XX% New Data from Phase X Trial $NRIX XX% New Data on Bexobrutideg in CLL $CGEM XX% Clinical Data in AML Presentation $ACLX X% New Positive Data for iMMagine-1 Study $LYEL X% New Clinical Data on Ronde-Cel $EVAX X% New data for cancer vaccine candidate $AUTL X% Initial Clinical Data in Pediatric r/r B-ALL $ALXO X% Positive Results from Phase X Trial $ARVN X% Preclinical Data on ARV-393 and Glofitamab $IRON X% Positive Data from RALLY-MF Trial $SLS 3%"  
[X Link](https://x.com/BiopharmIQ/status/1998082629225304409)  2025-12-08T17:29Z 28.1K followers, 4773 engagements


"$OVID up XX% 📈 OV329 shows strong Ph1 results. Favorable safety no eye issues. Now advancing to Ph2a. Initiate in Q2 2026 and completion in mid-2027 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1974139189806665913)  2025-10-03T15:47Z 28.1K followers, 1393 engagements


"💰 $BMY to acquire Orbital Tx Adds OTX-201 an in vivo CAR-T Extends $BMY s cell tx into autoimmune diseases Check out our free biopharma M&A tracker: 👇 Provides info on past M&A activity"  
[X Link](https://x.com/BiopharmIQ/status/1976677604234314053)  2025-10-10T15:54Z 28.1K followers, 1343 engagements


"$INBX up XX% 📈 Ozekibart Topline Results PFS doubled in chondrosarcoma trial 1st tx w/ proven PFS benefit Manageable safety; mild AEs BLA filing planned Q2 2026 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1981755932301496633)  2025-10-24T16:13Z 28.1K followers, 1326 engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $IDYA Phase X $IDYA Phase 2/3 $VOR Phase X $KYTX Phase X $VOR Phase X $IFRX Phase 2a $IFRX Phase 2b $JAGX Phase X $VRCA Phase X $ELDN Phase X $VERA Phase X $EVAX Phase X $ALXO Phase X $ALT Phase 2b $VOR Phase X $KZR Phase 2a $ARTV Phase 2a $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $IMMP Phase 2/3 $ALDX Phase X $TLPH Phase X $INAB Phase X $ALNY Phase X $LLY Phase X $BBIO Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $JAZZ Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase 2"  
[X Link](https://x.com/BiopharmIQ/status/1982535287143379054)  2025-10-26T19:50Z 28.1K followers, 28.9K engagements


"$BBIO up X% 📈 Encaleret Ph3 positive in ADH1 XX% met Ca targets vs X% SOC NDA filing planned H1 2026 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1983576518912885032)  2025-10-29T16:47Z 28.1K followers, 1501 engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $KZIA Phase X $NVS Phase X $NAMS Phase X $DNLI Phase 2/3 $LSTA Phase 2b $INKT Phase X $STOK Phase X $ADAG Phase X $PBYI Phase X $CNTA Phase 2a $NAMS Phase X $ELDN Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X Check out the image for more details"  
[X Link](https://x.com/BiopharmIQ/status/1987607309854679521)  2025-11-09T19:44Z 28.1K followers, XXX engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IRON DISC-0974 $ADCT ZYNLONTA + rituximab $INCY Monjuvi (Tafasitamab) Access our FREE Big Mover Report"  
[X Link](https://x.com/BiopharmIQ/status/1987607312622915916)  2025-11-09T19:44Z 28.1K followers, 1983 engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IRON 10/34 🔥 $ADCT 3/34 $INCY 1/34 Access our FREE hedge fund screener & search your fav tickers"  
[X Link](https://x.com/BiopharmIQ/status/1987607315349217639)  2025-11-09T19:44Z 28.1K followers, 1857 engagements


"$DAWN $MRSN 🔥 Day One Biopharmaceuticals is set to acquire Mersana Therapeutics - deal worth up to $285M - shareholders receive $25/sh cash upfront plus up to $30.25/sh potential CVR - payouts tied to key milestones for Emi-Le & an existing collaboration MRSN lead asset: - Emi-Le is a B7-H4directed Dolasynthen ADC being developed for triple-negative breast cancer & adenoid cystic carcinoma - closing expected by Jan 2026"  
[X Link](https://x.com/BiopharmIQ/status/1988991272342942114)  2025-11-13T15:24Z 28.1K followers, 6256 engagements


"$VNDA up XX% 📈 Tradipitant cuts vomiting from Wegovy by XX% Could reduce 30-50% tx dropouts Ph3 trials start early 2026 Targets $50B+ GLP-1 market side effects Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1990803865802006881)  2025-11-18T15:26Z 28.1K followers, 1226 engagements


"📣 Join our Biotech Daily Stock Moves community. 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing Visit the link to join our community.👇"  
[X Link](https://x.com/BiopharmIQ/status/1990803868121534956)  2025-11-18T15:26Z 28.1K followers, 1144 engagements


"$EYPT up X% 📈 IDSMC backs Duravuyu in Ph3 wet AMD trials No safety concerns Enrollment complete with 900+ patients Topline data expected mid-2026 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1991182272956100703)  2025-11-19T16:30Z 28.1K followers, 1253 engagements


"🧬 Biotech Stock News 11/20 @ Open $EVAX XX% Positive data for CMV vaccine program $GANX X% Preclinical GT-02287 Data Presented $CGEM X% Rolling Submission for New Drug Application $REGN X% FDA Approves Injection for Macular Edema $HUMA X% Presentations Highlight Positive ATEV Clinical Results $PRTA X% Poster Presentation on TDP-43 Program $NUVL X% FDA Accepts New Drug Application $AGEN X% End-of-Year Stakeholder Webcast on GI Oncology $PTCT X% To Host R&D Day $OCGN X% CEO to Present at Emerging Growth Conference $MAIA X% Telomere Targeting Efficacy Presentation $ONC X% Leadership in B-cell"  
[X Link](https://x.com/BiopharmIQ/status/1991538459509686445)  2025-11-20T16:05Z 28.1K followers, 5415 engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $RNA Delpacibart Etedesiran $COGT Bezuclastinib $ADVM Ixoberogene soroparvovec Access our FREE Big Mover Report"  
[X Link](https://x.com/BiopharmIQ/status/1992694183036076271)  2025-11-23T20:38Z 28.1K followers, 1490 engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $RNA 14/34 🔥 $COGT 12/34 🔥 $ADVM 3/34 Access our FREE hedge fund screener & search your fav tickers"  
[X Link](https://x.com/BiopharmIQ/status/1992694185204613413)  2025-11-23T20:38Z 28.1K followers, 1455 engagements


"$XENE up X% 📈 Azetukalner long-term OLE data @ AES 2025 48mt update shows extended seizure-free periods Posters also cover depression burden & ASM titration challenges Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1993367559530487986)  2025-11-25T17:13Z 28.1K followers, 1232 engagements


"📣 Join our Biotech Daily Stock Moves community. 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing Visit the link to join our community.👇"  
[X Link](https://x.com/BiopharmIQ/status/1995897925487272144)  2025-12-02T16:48Z 28.1K followers, 1026 engagements


"📌 Biotech Stock News 12/3 @ Open $CAPR XXX% Deramiocel Topline Results Reported $PHVS XX% Deucrictibant Topline Data Reported $TARA X% TARA-002 Interim Data Reported $KURA X% Virtual Investor Event on AML Data $CRNX X% First Patient Dosed in Trial $CGTX X% Zervimesine Full Enrollment Reached $RLMD X% Presentation of NDV-01 Ph2 Data $BMY X% Continuation of ADEPT-2 Ph3 Study $PYPD X% D-PLEX FDA Pre-NDA Meeting Minutes $IXHL X% FDA Fast Track for IHL-42X $XENE X% Webinar on Azetukalner & Epilepsy Data $GLSI X% Global Update on FLAMINGO-01 $BCRX X% Early Termination of HSR Waiting Period $STRO"  
[X Link](https://x.com/BiopharmIQ/status/1996251665104851046)  2025-12-03T16:14Z 28.1K followers, 5009 engagements


"$CAPR up XXX% 📈 Deramocel shows consistent safety across patients Ph3 HOPE-3 meets primary endpoint Cardiac function improves with significant LVEF gain Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1996251668992979382)  2025-12-03T16:14Z 28.1K followers, 1367 engagements


"📣 Join our Biotech Daily Stock Moves community. 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing Visit the link to join our community.👇"  
[X Link](https://x.com/BiopharmIQ/status/1996251671551410294)  2025-12-03T16:14Z 28.1K followers, XXX engagements


"📌 Biotech Stock News 12/5 @ Open $PRAX XX% Relutrigine Results; Ulixacaltamide Pre-NDA Mtg. $VNDA X% FDA Lifts Clinical Hold on Tradipitant $CAPR X% Pricing of $150M Public Offering $BMEA X% COVALENT-111 Results @ WCIRDC $RAPP X% RAP-219 New Data $OSTX X% FDA PDUFA Waiver; EMA Marketing Eligibility $AMLX X% AMX0114 New Safety & Tolerability Data $BMY X% First CAR T Therapy Approved for MZL $NTRA X% Acquires Foresight Diagnostics $XENE X% Azetukalner 48-Month OLE Data $AAPG X% Ph3 Study of Olverembatinib Cleared $BIIB X% Zorevunersen Presentation @ AES'25 $AMRX X% CREXONT Ph4 Results $IDYA 0%"  
[X Link](https://x.com/BiopharmIQ/status/1996982942627983554)  2025-12-05T16:40Z 28.1K followers, 4602 engagements


"$PRAX up XX% 📈 Relutrigine strong benefit in SCN2A & SCN8A DEEs EMBOLD study halted early for efficacy Meeting w/ FDA to discuss the results & NDA path Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1996982946302251198)  2025-12-05T16:40Z 28.1K followers, 1079 engagements


"📣 Join our Biotech Daily Stock Moves community. 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing Visit the link to join our community.👇"  
[X Link](https://x.com/BiopharmIQ/status/1996982949041033552)  2025-12-05T16:40Z 28.1K followers, 1002 engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $PRAX Phase X $INBX Phase 2/3 $MLTX Phase X $BLTE Phase X $ADVM Phase X $ALT Phase 2b $INSM Phase X $KMDA Phase X $MREO Phase X $ATOS Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $SLS Phase X $PCVX Phase X $IMMP Phase 2/3 $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $DNLI"  
[X Link](https://x.com/BiopharmIQ/status/1992694179575840845)  2025-11-23T20:38Z 28.1K followers, 1391 engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IRON DISC-0974 $NKTR Rezpegaldesleukin (NKTR-358) $MGNX Lorigerlimab + docetaxel Access our FREE Big Mover Report"  
[X Link](https://x.com/BiopharmIQ/status/1995242794013884725)  2025-11-30T21:25Z 28.1K followers, 3243 engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IRON 10/34 🔥 $NKTR 6/34 $MGNX 3/34 Access our FREE hedge fund screener & search your fav tickers"  
[X Link](https://x.com/BiopharmIQ/status/1995242796064899576)  2025-11-30T21:25Z 28.1K followers, 2399 engagements


"📢 M&A News: $LLY to Acquire $ADVM $3.56/sh upfront + up to $8.91/sh CVR valuing the deal at up to $1.3B Adds Ixo-vec a one-time intravitreal gene therapy for wet AMD Ph3 (ARTEMIS trial) with Fast Track RMAT and PRIME designations $LLY provided $65M bridge financing to fund ongoing trials ahead of deal close in Q4 2025 See images for more details 👇"  
[X Link](https://x.com/BiopharmIQ/status/1981726008521945118)  2025-10-24T14:14Z 28.1K followers, 3685 engagements


"🧬 Biopharma Weekly Recap 📝 This week in biotech: Biotech week spotlighted ADC momentum big win for $VTYX fresh FDA approvals and renewed investor buzz around gene editing and undervalued small caps. See interesting posts/ppl to check out 👇 @RheumatDocX 🧬 Monoclonal Antibody Nomenclature (WHO 2021 Update) @yaireinhorn This excellent piece by WSJs @DrSamuelBHume X breakthroughs in medicine this week @PersimmonTI A Visual History of Approved ADCs @ohadhammer Similar story in SCLC with ADCs targeting B7H3 DLL3 SEZ6 all reporting. @HatedMoats 🚨 Novo News - FDA approval ✅ @BowTiedBiotech ESMO"  
[X Link](https://x.com/BiopharmIQ/status/1982120899949232285)  2025-10-25T16:23Z 28.1K followers, 15.7K engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $PHVS Phase X $VTGN Phase X $ZBIO Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase X $BLTE Phase X $ADVM Phase X $MBRX Phase X $ENGN Phase X $CTNM Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $ATOS Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $IRON Phase X $ADCT Phase X $AGIO Phase X $SLS Phase X $PCVX Phase X $ALZN Phase X $ACLX Phase X $ELDN Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X Check out the image for more details"  
[X Link](https://x.com/BiopharmIQ/status/1982535298711208426)  2025-10-26T19:50Z 28.1K followers, 1435 engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $ADVM Ixoberogene soroparvovec (Ixo-vec) $VTGN Fasedienol (PH94B) $MREO Setrusumab (UX143) Access our FREE Big Mover Report"  
[X Link](https://x.com/BiopharmIQ/status/1982535302238650611)  2025-10-26T19:50Z 28.1K followers, 2516 engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $ADVM 3/34 $VTGN 2/34 $MREO 1/34 Access our FREE hedge fund screener & search your fav tickers"  
[X Link](https://x.com/BiopharmIQ/status/1982535304482590929)  2025-10-26T19:50Z 28.1K followers, 2557 engagements


"📌 Biotech Stock News 11/7 @ Open $THAR XX% Closes $545M Private Placement $BCAB X% Median OS of XXXX months in Sarcomas $AKBA X% Vafseo Post Hoc Data $HALO X% FDA Approves DARZALEX Faspro $AZN X% NATRON Ph3 trial results $CNTX X% CT-95 and CT-202 Programs $ELTX X% Cytolytic T Cell Responses in Trial $TMO X% Authorizes $5B Share Repurchases $MIRM X% Leadership in Liver Disease Innovation $AKRO X% New Analyses from Ph2b Trials $IMCR X% Ph1 data for hepatitis B $INKT X% Durable Responses with Allo-iNKT Tx $HCWB X% Preclinical Data @ SITC'25 $JNJ X% First FDA-approved treatment for myeloma $ASMB"  
[X Link](https://x.com/BiopharmIQ/status/1986829083494469767)  2025-11-07T16:12Z 28.1K followers, 2784 engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $PRAX Phase X $INBX Phase 2/3 $MLTX Phase X $BLTE Phase X $ADVM Phase X $ALT Phase 2b $RYTM Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $SLS Phase X $PCVX Phase X $IMMP Phase 2/3 $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS"  
[X Link](https://x.com/BiopharmIQ/status/1995242789958045700)  2025-11-30T21:25Z 28.1K followers, 1456 engagements


"📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"  
[X Link](https://x.com/BiopharmIQ/status/1998432564135309794)  2025-12-09T16:40Z 28.1K followers, 3596 engagements


"🧬 Biotech Stock News 09/05 Brought to you by Barb X on the rise 📈 $ADAG X% $HCM X% $CGON X% X under pressure 📉 $AMRX -X% $PALI -X% $DRUG -X% Catch the full breakdown in the latest video 🎥"  
[X Link](https://x.com/BiopharmIQ/status/1964072716689957130)  2025-09-05T21:06Z 28.1K followers, 4030 engagements


"How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above 🤔 $RVMD 12/34 $ZLAB 4/34 $LXEO 4/34 $VKTX 4/34 $VTYX 3/34 $IPSC 2/34 $SMMT 1/34 $NTLA 1/34 Access our FREE screener to check your fave stocks 👇"  
[X Link](https://x.com/BiopharmIQ/status/1982120906093916657)  2025-10-25T16:23Z 28.1K followers, 1885 engagements


"Avoro Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND $UTHR $MDGL $ARGX $KRYS $ARWR $KYMR $MRUS $RNA $APLS $CNTA $QURE $XENE $AKRO $VERA $SLNO $GPCR $TRML $OCUL $FOLD *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"  
[X Link](https://x.com/BiopharmIQ/status/1989368536977014819)  2025-11-14T16:23Z 28.1K followers, 7393 engagements


"OrbiMed Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XXX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXX% Top Holdings: $EWTX (5.9%) $BSX (5.6%) $LLY (5.4%) $SINX (4.3%) $ELVN (3.8%) $ALNY (3.2%) $SYK (3.1%) $EW (3.1%) $ISRG (3.0%) $ARGX (3.0%) $SION (2.6%) $UPB (2.5%) $IRON (2.2%) $CAI (2.2%) $SPRY (2.0%) $RNA (1.7%) $MBX (1.6%) $CGON (1.6%) $NTRA (1.6%) $AXSM (1.5%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details👇"  
[X Link](https://x.com/BiopharmIQ/status/1989468504354119705)  2025-11-14T23:00Z 28.1K followers, 9233 engagements


"$XCUR up XX% 📈 Burixafor Ph2: MM mobilization XX% achieved primary endpoint goal Safe with daratumumab-exposed patients Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"  
[X Link](https://x.com/BiopharmIQ/status/1998432568337903950)  2025-12-09T16:40Z 28.1K followers, 1012 engagements


"November Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $ARWR - Plozasiran (ARO-APOC3) $KURA - Ziftomenib $ASND - TransCon CNP See this months PDUFA calendar below"  
[X Link](https://x.com/BiopharmIQ/status/1985473014432256005)  2025-11-03T22:23Z 28.1K followers, 40.7K engagements


"🧬 Biotech Stock News 9/5 @ Open $ADAG X% ADG126 Highlighted at CSCO Meeting $HCM X% Clinical Data Presentation at CSCO $CGON X% 24-month Durability and Tolerability Data $MLYS X% Subgroup Analyses of Ph3 Trial $MLYS X% Closing of $287.5M Offering $RGNX X% 12-month Pivotal Data from RGX-121 Trial $AVDL X% New Data on LUMRYZ $GILD X% Partnership for HIV Prevention Initiative $MDT X% Robotic Surgery System Meets Safety Endpoints $RHHBY X% New Data on Vabysmo for Wet AMD $THTX X% Availability of EGRIFTA WR for Injection $QURE X% Initial AMT-191 Phase 1/2a Data $AMRX -X% FDA Approval for"  
[X Link](https://x.com/BiopharmIQ/status/1964010514323034357)  2025-09-05T16:59Z 28.1K followers, 6762 engagements


"📌 Biotech Stock News 09/26 @ Open $CRNX XX% FDA Approval of PALSONIFY for Acromegaly $GUTS XX% REMAIN-1 Midpoint Cohort Data $AMRX X% BLA Submission of Xolair Biosimilar $SNY X% Expands Patient Affordability Program $KALV X% New EKTERLY Data at Allergy Congress $CDTX X% First Participants Dosed in Ph3 Trial $KURA X% Publication of Ziftomenib Data in AML $LLY X% Marketing Authorization for Alzheimer's treatment $LLY X% FDA Approves Inluriyo for Breast Cancer $ABBV X% NDA Submission for Tavapadon $THTX X% Completion of Acquisition by Future Pak $AMGN X% $650M U.S. Manufacturing Expansion $REGN"  
[X Link](https://x.com/BiopharmIQ/status/1971608845396168828)  2025-09-26T16:12Z 28.1K followers, 7246 engagements


"🧬 Biotech Stock News 09/26 Brought to you by Barb On the rise 📈 $CRNX XX% $GUTS XX% $AMRX X% Under pressure 📉 $AMGN -X% $REGN -X% $QURE -X% Catch the full breakdown in the latest video"  
[X Link](https://x.com/BiopharmIQ/status/1971640435258150937)  2025-09-26T18:18Z 28.1K followers, 3254 engagements


"Baker Brothers Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ONC (22%) $INCY (19%) $MDGL (7.1%) $INSM (7%) $ACAD (6.6%) $SMMT (5%) $RYTM (4.1%) $RVMD (3.2%) $CELC (2.8%) $KYMR (2.7%) $KOD (2%) $ALKS (1.8%) $ABCL (1%) $EWTX (0.9%) $KNSA (0.8%) $STOK (0.8%) $IMTX (0.7%) $GRAL (0.7%) $IDYA (0.6%) $IMVT (0.6%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held"  
[X Link](https://x.com/BiopharmIQ/status/1989473329401692336)  2025-11-14T23:19Z 28.1K followers, 19.7K engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $INAB Phase X $CRDL Phase X $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $STOK Phase X $GLPG Phase X $NRIX Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK"  
[X Link](https://x.com/BiopharmIQ/status/1990156659042529711)  2025-11-16T20:34Z 28.1K followers, 31.3K engagements


"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved ✅ $BMY - Breyanzi (lisocabtagene maraleucel) $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea (aflibercept) $AMRX"  
[X Link](https://x.com/BiopharmIQ/status/1996624003088503145)  2025-12-04T16:53Z 28.1K followers, 7660 engagements


"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"  
[X Link](https://x.com/BiopharmIQ/status/1998789058378739986)  2025-12-10T16:17Z 28.1K followers, 2151 engagements


"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"  
[X Link](https://x.com/BiopharmIQ/status/1998792850193232042)  2025-12-10T16:32Z 28.1K followers, 1229 engagements